OBJECTIVE	We sought to investigate whether these anti-inflammatory effects could yield early responding biomarkers for TZD action in Type 2 diabetes mellitus ( T2DM ) patients and healthy volunteers ( HV ) to expedite early clinical development of novel compounds .\